210 related articles for article (PubMed ID: 26584874)
1. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy.
Chia J; Eroglu FK; Özen S; Orhan D; Montealegre-Sanchez G; de Jesus AA; Goldbach-Mansky R; Cowen EW
J Am Acad Dermatol; 2016 Jan; 74(1):186-9. PubMed ID: 26584874
[TBL] [Abstract][Full Text] [Related]
2. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.
Munoz J; Rodière M; Jeremiah N; Rieux-Laucat F; Oojageer A; Rice GI; Rozenberg F; Crow YJ; Bessis D
JAMA Dermatol; 2015 Aug; 151(8):872-7. PubMed ID: 25992765
[TBL] [Abstract][Full Text] [Related]
3. Type I interferonopathy in a young adult.
Manoussakis MN; Mavragani CP; Nezos A; Zampeli E; Germenis A; Moutsopoulos HM
Rheumatology (Oxford); 2017 Dec; 56(12):2241-2243. PubMed ID: 28968819
[No Abstract] [Full Text] [Related]
4. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
[No Abstract] [Full Text] [Related]
5. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.
Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067
[TBL] [Abstract][Full Text] [Related]
6. A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy.
Raffaele CGL; Messia V; Moneta G; Caiello I; Federici S; Pardeo M; Bracaglia C; De Benedetti F; Insalaco A
Rheumatology (Oxford); 2020 Apr; 59(4):905-907. PubMed ID: 31598716
[No Abstract] [Full Text] [Related]
7. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
Yu ZX; Song HM
World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
[TBL] [Abstract][Full Text] [Related]
8. [Type I interferonopathies].
Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
[TBL] [Abstract][Full Text] [Related]
9. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
[TBL] [Abstract][Full Text] [Related]
10. Type I interferonopathies in pediatric rheumatology.
Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
[TBL] [Abstract][Full Text] [Related]
11. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.
Wang Y; Wang F; Zhang X
Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478
[TBL] [Abstract][Full Text] [Related]
12. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
[TBL] [Abstract][Full Text] [Related]
13. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
14. Blue (or purple) toes: chilblains or chilblain lupus-like lesions are a manifestation of Aicardi-Goutières syndrome and familial chilblain lupus.
Prendiville JS; Crow YJ
J Am Acad Dermatol; 2009 Oct; 61(4):727-8. PubMed ID: 19751886
[No Abstract] [Full Text] [Related]
15. Genetic interferonopathies: An overview.
Eleftheriou D; Brogan PA
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.
Volpi S; Insalaco A; Caorsi R; Santori E; Messia V; Sacco O; Terheggen-Lagro S; Cardinale F; Scarselli A; Pastorino C; Moneta G; Cangemi G; Passarelli C; Ricci M; Girosi D; Derchi M; Bocca P; Diociaiuti A; El Hachem M; Cancrini C; Tomà P; Granata C; Ravelli A; Candotti F; Picco P; DeBenedetti F; Gattorno M
J Clin Immunol; 2019 Jul; 39(5):476-485. PubMed ID: 31144250
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies.
Lodi L; Melki I; Bondet V; Seabra L; Rice GI; Carter E; Lepelley A; Martin-Niclós MJ; Al Adba B; Bader-Meunier B; Barth M; Blauwblomme T; Bodemer C; Boespflug-Tanguy O; Dale RC; Desguerre I; Ducrocq C; Dulieu F; Dumaine C; Ellul P; Hadchouel A; Hentgen V; Hié M; Hully M; Jeziorski E; Lévy R; Mochel F; Orcesi S; Passemard S; Pouletty M; Quartier P; Renaldo F; Seidl R; Shetty J; Neven B; Blanche S; Duffy D; Crow YJ; Frémond ML
J Clin Immunol; 2021 Apr; 41(3):603-609. PubMed ID: 33411153
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Novel SAVI-Causing Variants in
Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
Front Immunol; 2021; 12():636225. PubMed ID: 33833757
[TBL] [Abstract][Full Text] [Related]
19. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
Wu J; Zhou Q; Zhou H; Lu M
Pediatr Rheumatol Online J; 2023 Oct; 21(1):131. PubMed ID: 37884945
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]